Physician profile
Jonathan Scher
NPI 1962513499
$1,379.69
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $302 · 2022: $124 · 2023: $17.29 · 2024: $84.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $237.00 | 2019-2020 | |
| Aspira Women'S Health INC | $123.51 | 2022 | |
| Vertical Pharmaceuticals, LLC | $118.09 | 2019 | |
| Exeltis, USA INC. | $109.71 | 2019 | |
| Aytu Biopharma, INC. | $109.53 | 2019-2020 | |
| Ibsa Pharma INC. | $87.71 | 2019-2020 | |
| Astellas Pharma US INC | $72.14 | 2019-2020 | |
| Highridge Medical LLC | $64.20 | 2024 | Mobi-C Plug & Fit US |
| Therapeuticsmd, INC. | $61.99 | 2019 | |
| Avion Pharmaceuticals | $60.20 | 2019-2020 | |
| Antares Pharma, INC. | $59.13 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $54.05 | 2020 | |
| Amarin Pharma, INC. | $50.16 | 2019 | |
| Novo Nordisk INC | $44.07 | 2020 | |
| Amag Pharmaceuticals, INC. | $37.54 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $37.29 | 2019 | |
| Hologic Sales and Service, LLC | $20.08 | 2024 | Aptima |
| Exact Sciences Corporation | $17.29 | 2023 | Cologuard Collection Kit |
| Ascend Therapeutics US, LLC | $16.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Scher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.